Skip to main navigation Skip to main content

Clin Mol Hepatol : Clinical and Molecular Hepatology

OPEN ACCESS
ABOUT
BROWSE ARTICLES
FOR CONTRIBUTORS

Page Path

2
results for

"Alcoholics"

Article category

Keywords

Publication year

"Alcoholics"

Original Article

Gut-derived lipopolysaccharide promotes alcoholic hepatosteatosis and subsequent hepatocellular carcinoma by stimulating neutrophil extracellular traps through toll-like receptor 4
Yang Liu, Xin Zhang, Shuo Chen, Jiazhong Wang, Shuo Yu, Yiming Li, Meng Xu, Harouna Aboubacar, Junhui Li, Tao Shan, Jixin Wang, Gang Cao
Clin Mol Hepatol 2022;28(3):522-539.
Published online May 4, 2022
DOI: https://doi.org/10.3350/cmh.2022.0039
Background/Aims
Binge drinking leads to many disorders, including alcoholic hepatosteatosis, which is characterized by intrahepatic neutrophil infiltration and increases the risk of hepatocellular carcinoma (HCC). Molecular mechanisms may involve the migration of bacterial metabolites from the gut to the liver and the activation of neutrophil extracellular traps (NETs).
Methods
Serum samples from both binge drinking and alcohol-avoiding patients were analyzed. Mouse models of chronic plus binge alcohol-induced hepatosteatosis and HCC models were used.
Results
A marker of NETs formation, lipopolysaccharide (LPS), was significantly higher in alcoholic hepatosteatosis and HCC patients and mice than in controls. Intrahepatic inflammation markers and HCC-related cytokines were decreased in mice with reduced NET formation due to neutrophil elastase (NE) deletion, and liver-related symptoms of alcohol were also alleviated in NE knockout mice. Removal of intestinal bacteria with antibiotics led to decreases in markers of NETs formation and inflammatory cytokines upon chronic alcohol consumption, and development of alcoholic hepatosteatosis and HCC was also attenuated. These functions were restored upon supplementation with the bacterial product LPS. When mice lacking toll-like receptor 4 (TLR4) received chronic alcohol feeding, intrahepatic markers of NETs formation decreased, and hepatosteatosis and HCC were alleviated.
Conclusions
Formation of NETs following LPS stimulation of TLR4 upon chronic alcohol use leads to increased alcoholic steatosis and subsequent HCC.

Citations

Citations to this article as recorded by  Crossref logo
  • Neutrophil extracellular traps mediate pathophysiology of hepatic cells during liver injury
    Ki M. Mak, Aditya C. Shekhar, Selena Y. Ding
    The Anatomical Record.2026; 309(1): 214.     CrossRef
  • Alterations in Gut Microbiota and Metabolism in Cirrhotic Portal Hypertension: Implications for Disease Progression
    Qun Zhang, Jinghua Cui, Yixin Hou, Lining Guo, Hai Li, Guiqin Zhou, Xiaojing Wang, Bingbing Zhu, Ke Shi, Yi Zhang, Yufei Bi, Yanqiu Li, Lina Sun, Ying Feng, Jing Yuan, Xianbo Wang
    Alimentary Pharmacology & Therapeutics.2026; 63(4): 538.     CrossRef
  • Bielong Ruangan decoction inhibits tumor growth and improves immune response in a hepatocellular carcinoma mouse model through gut microbiota
    Ruoyu Wang, Dan Tang, Lingyu Wu, Longyun Ou, Lin Ding, Jiacheng Jiang, Yunan Wu
    The International Journal of Biochemistry & Cell Biology.2026; 190: 106873.     CrossRef
  • Multitarget natural compounds taming NETosis: A translational strategy for cancer and inflammatory diseases
    Wentao Jia, Jinbo Zhang, Yan Shang, Shanrong Liu
    Cancer Letters.2026; 636: 218103.     CrossRef
  • Gut microbiota's role in NAFLD- and HBV/HCV-related hepatocellular carcinoma: Mechanisms and therapeutic implications
    Gursimran Singh, Shazia Ansari, Satyam Yadav, Khadga Raj Aran
    Microbial Pathogenesis.2026; 211: 108273.     CrossRef
  • A stage specific NETs-related signature in alcoholic steatohepatitis: from molecular subtyping to therapeutic vulnerabilities
    Wei Gao, Zhiyong Lin, Yuntao Bao, Mingjiang Liu, Guangtao Ma, Xianxiang Chen, Shuiping Yu, Yonglian Zeng
    Frontiers in Immunology.2026;[Epub]     CrossRef
  • The landscape of gut microbiota in hepatocarcinogenesis: a comprehensive review of pathogenesis and therapeutic interventions
    Zhi-Bo Yan, Cheng-Long Han, Ji-Sen Jia, Han Li, Dong-Hai Lu, Qi-Hang Cao, Yu-Xuan Wang, Ke-Fan Jiao, Qiao He, Sheng-Xuan Peng, Dao-Lin Zhang, Qiang Wang, Tao Li
    International Journal of Surgery.2026; 112(1): 1673.     CrossRef
  • Microbial Biomarkers for the Prevention and Diagnosis of Alcoholic Liver Disease
    Goo Hyun Kwon, Hyunjoon Park, Hyeong Seop Kim, Ki Kwang Oh, Jung A Eom, Kyeong Jin Lee, Min Ju Kim, Minsoo Kim, Jeong Su Kim, Sang Hak Han, Young Lim Ham, Ki Tae Suk
    Microorganisms.2026; 14(2): 449.     CrossRef
  • The Molecular Network of Neutrophil Extracellular Traps in Hepatocellular Carcinoma: Biogenesis, Function, and Therapeutic Implications
    Chang Liu, Jienan Lu, Yang Tian, Sinan Lu, Weili Wang, Jun Jiang, Xiang Zheng, Sheng Yan
    Molecules.2026; 31(4): 749.     CrossRef
  • Decoding the mechanistic basis of liver–muscle communication in health and disease
    Noha M. Gamil, Habiba A. Elsayed, Esraa T. Salah, Heba A. Mostafa, Riham A. El-Shiekh, Heba R. Ghaiad, Hebatollah E. Eitah
    Naunyn-Schmiedeberg's Archives of Pharmacology.2026;[Epub]     CrossRef
  • Fucoidan alleviates chemotherapy-induced steatohepatitis by regulating the gut–liver axis
    Yihang Cai, Yongyi Chen, Xiqin Bian, Changlin Sun, Jing Cheng, Haibo Liu, Lai Jin, Jianxin Ma, Wentao Liu
    International Immunopharmacology.2026; 175: 116390.     CrossRef
  • Targeting the Toll-Like Receptor 4 Ameliorates Heart Failure in Aged Mice by Inhibiting the Formation of Neutrophil Extracellular Traps
    H Liu, X Chen, Z Wu
    Physiological Research.2026; : 29.     CrossRef
  • Gut–liver axis molecular mechanisms in alcohol-associated liver disease
    Yuxuan Jiang, Cristina Llorente
    Alcohol.2026; 133: 48.     CrossRef
  • The versatile interplay between steatotic liver disease and liver cancer
    Mohammad Rahbari, Albert Gris-Oliver, Pierluigi Ramadori, David Aicher, Daniela Sia, Nisar P. Malek, Rohit Loomba, Ramon Bataller, Josep M. Llovet, Mathias Heikenwälder
    Nature Reviews Cancer.2026;[Epub]     CrossRef
  • Lipopolysaccharide, arbiter of the gut–liver axis, modulates hepatic cell pathophysiology in alcoholism
    Ki M. Mak, Aditya C. Shekhar
    The Anatomical Record.2025; 308(3): 975.     CrossRef
  • Could intratumoural microbiota be key to unlocking treatment responses in hepatocellular carcinoma?
    Kin Lam Yu, Sj Shen
    European Journal of Cancer.2025; 216: 115195.     CrossRef
  • The dual role of neutrophils in sepsis-associated liver injury
    Lexin Fang, Yu Song, Jiangtao Chen, Yueping Ding
    Frontiers in Immunology.2025;[Epub]     CrossRef
  • Roles of the gut microbiota in hepatocellular carcinoma: from the gut dysbiosis to the intratumoral microbiota
    Yiqin Wang, Yongqiang Li, Yong Lin, Chuangyu Cao, Dongcheng Chen, Xianguang Huang, Canhua Li, Haoming Xu, Huasheng Lai, Huiting Chen, Yongjian Zhou
    Cell Death Discovery.2025;[Epub]     CrossRef
  • Neutrophil elastase binds at the central domain of extracellular Toll-like receptor 4: AI prediction, docking, and validation in disease model
    Azeem Ali, Leena Gaba, Sujata Jetley, Imran A. Khan, Prem Prakash
    Scientific Reports.2025;[Epub]     CrossRef
  • Neutrophil extracellular traps (NETs) and NETosis in alcohol‐associated diseases: A systematic review
    Mohammed A. S. Khan, Byoung‐Joon Song, Xin Wang, Shams Iqbal, Gyongyi Szabo, Sulie L. Chang
    Alcohol, Clinical and Experimental Research.2025; 49(4): 697.     CrossRef
  • Toll Like Receptors Promote High Glucose-Induced Vascular Endothelial Cell Dysfunction by Regulating Neutrophil Extracellular Traps Formation
    Shirou Wu, Yahui Chen, Xiuming Jin, Jiayun Yu, Xueping Chen, Ting Wan
    Inflammation.2025; 48(5): 3542.     CrossRef
  • Regulatory role of gut microbiota in immunotherapy of hepatocellular carcinoma
    Jiajia Du, Yan Guan, Erlei Zhang
    Hepatology International.2025; 19(3): 507.     CrossRef
  • Food additive β-caryophyllene mitigates alcoholic steatohepatitis by dual modulation of inflammation and lipid metabolism: a diet-based intervention strategy
    Jun-Liang Yang, Zhi-Hong Zhang, Xue-Li Jiang, Si-Qi Wang, Yan-Ling Wu, Ji-Xing Nan, Li-Hua Lian
    Food & Function.2025; 16(13): 5393.     CrossRef
  • Dietary yeast extract prevents alcoholic liver disease in mice via correcting gut dysbiosis and improving intestinal barrier function
    Hao Han, Lei Tian, Yajing Dong, Yanyang Han, Xiaoman Wang, Qian Cheng, Haibo Zhang, Yan Zhang
    Food Science and Human Wellness.2025; 14(6): 9250146.     CrossRef
  • Microbial Modulation of the Gut–Liver Axis in Autoimmune Liver Diseases
    Shihui Wei, Juan Lu
    Seminars in Liver Disease.2025; 45(04): 498.     CrossRef
  • Gut Microbiota and the Gut-liver Axis in Hepatocellular Carcinoma: A Comprehensive Review of Pathogenesis and Therapeutic Strategies
    Satyam Yadav, Ranjeet Kumar
    Anti-Cancer Agents in Medicinal Chemistry.2025; 25(17): 1287.     CrossRef
  • Co-fermentation of honeysuckle-Cassia seeds by Lactobacillus acidophilus and Bacillus subtilis: A new approach to attenuate alcohol-induced acute gastric mucosal damage and modulate immune response
    Mengtian Zhou, Xinran Cao, Huike Ji, Zhaoxue Liu, Hongyi Guo, Yingao Zhang, Yongqi Huang, Fang Wang, Meixia Pang, Ying Wei
    Food Research International.2025; 222: 117639.     CrossRef
  • Neutrophil extracellular traps as therapeutics target in vascular aging
    Jie Mao, Shuang Wu, Zelin Yan, Guiping Huang, Yihua Yu
    Frontiers in Immunology.2025;[Epub]     CrossRef
  • Gut microbial metabolites in cancer immunomodulation
    Hengshuo Liu, Xingyu Xiong, Weizhen Zhu, Sheng Wang, Weichao Huang, Guoqing Zhu, Hang Xu, Lu Yang
    Molecular Cancer.2025;[Epub]     CrossRef
  • Unveiling the covert interaction between gut microbiota and neutrophils to drive colorectal cancer metastasis
    Peiliang Shen, Peng Cheng, Yanan Li, Gangfan Zong, Rui Deng, Cheng Qian, Yang Zhao, Zhonghong Wei, Yin Lu
    European Journal of Pharmacology.2024; 962: 176217.     CrossRef
  • Toxoplasma gondii-induced neutrophil extracellular traps are relevant to glycolysis, TLR2, and TLR4 MAPK signaling pathway in goats
    Zha Jin, Qinqin Jin, Meiyi Chen, Wei Liu, Hongrong Hong, Yuqian Jiang, Xinxin Gao, Yuxiao Qian, Zedong Wang, Quan Liu, Zhengkai Wei
    Parasitology Research.2024;[Epub]     CrossRef
  • γδ T Cells: A Game Changer in the Future of Hepatocellular Carcinoma Immunotherapy
    Stavros P. Papadakos, Konstantinos Arvanitakis, Ioanna E. Stergiou, Maria-Loukia Koutsompina, Georgios Germanidis, Stamatios Theocharis
    International Journal of Molecular Sciences.2024; 25(3): 1381.     CrossRef
  • The causal correlation between gut microbiota abundance and pathogenesis of cervical cancer: a bidirectional mendelian randomization study
    Hua Yang
    Frontiers in Microbiology.2024;[Epub]     CrossRef
  • Platelets in Alcohol-Associated Liver Disease: Interaction With Neutrophils
    Juan Wang, Xianda Wang, Haodong Peng, Zijian Dong, Suthat Liangpunsakul, Li Zuo, Hua Wang
    Cellular and Molecular Gastroenterology and Hepatology.2024; 18(1): 41.     CrossRef
  • An integrated network pharmacology approach reveals that Ampelopsis grossedentata improves alcoholic liver disease via TLR4/NF-κB/MLKL pathway
    Ping Qiu, Ai Mi, Chunlan Hong, Shuo Huang, Qing Ma, Qihan Luo, Jiang Qiu, He Jiang, Yufan Chen, Fangming Chen, Honghao Yan, Jinkai Zhao, Yu Kong, Yu Du, Changyu Li, Desong Kong, Thomas Efferth, Dayong Lou
    Phytomedicine.2024; 132: 155658.     CrossRef
  • Expansion of effector regulatory T cells in steroid responders of severe alcohol-associated hepatitis
    Min Woo Kang, Soon Kyu Lee, Eun Ji Jang, Jong Geun Park, Deok Hwa Seo, Ji Won Han, Jae Sung Yoo, Jung Hyun Kwon, Soon Woo Nam, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon, Pil Soo Sung
    Liver Transplantation.2024; 30(9): 877.     CrossRef
  • Imaging and Therapy of Tumors Based on Neutrophil Extracellular Traps
    Yongwei Hao, Dalin Liu, Kaiyuan Wang, Qian Liu, Hongli Chen, Shenglu Ji, Dan Ding
    Small Science.2024;[Epub]     CrossRef
  • Understanding gut dysbiosis for hepatocellular carcinoma diagnosis and treatment
    Jingjing Yu, Xiaoping Chen, Xiangliang Yang, Bixiang Zhang
    Trends in Endocrinology & Metabolism.2024; 35(11): 1006.     CrossRef
  • Timing, initiation and function: An in-depth exploration of the interaction network among neutrophil extracellular traps related genes in acute pancreatitis
    Haoyu Zhang, Zheng Wang, Jie Li, Yuchen Jia, Fei Li
    International Immunopharmacology.2024; 141: 112923.     CrossRef
  • Interaction between intratumoral microbiota and neutrophils influences tumor progression
    Mengyuan Hu
    American Journal of Clinical and Experimental Immunology.2024; 13(5): 233.     CrossRef
  • Alcohol-related liver disease (ALD): current perspectives on pathogenesis, therapeutic strategies, and animal models
    Xiao Hong, Shuo Huang, He Jiang, Qing Ma, Jiang Qiu, Qihan Luo, Chunlu Cao, Yiyang Xu, Fuzhe Chen, Yufan Chen, Chunfeng Sun, Haozhe Fu, Yiming Liu, Changyu Li, Fangming Chen, Ping Qiu
    Frontiers in Pharmacology.2024;[Epub]     CrossRef
  • G-CSF exacerbates liver injury in a mouse model of autoimmune hepatitis
    Yi Shen, Yifeng Liu, Kexin Yu, Mengyi Shen, Li Yang
    Journal of Hepatology.2023; 79(1): e29.     CrossRef
  • Structure and hepatoprotective activity of Usp10/NF-κB/Nrf2 pathway-related Morchella esculenta polysaccharide
    Shanshan Teng, Yongfeng Zhang, Xinghui Jin, Yanfeng Zhu, Lanzhou Li, Xiaowei Huang, Di Wang, Zhe Lin
    Carbohydrate Polymers.2023; 303: 120453.     CrossRef
  • Neutrophil extracellular traps in tumor progression and immunotherapy
    Meina Yan, Yifeng Gu, Hongxia Sun, Qinghong Ge
    Frontiers in Immunology.2023;[Epub]     CrossRef
  • The Role of TLR4 in the Immunotherapy of Hepatocellular Carcinoma: Can We Teach an Old Dog New Tricks?
    Stavros P. Papadakos, Konstantinos Arvanitakis, Ioanna E. Stergiou, Vasileios Lekakis, Spyridon Davakis, Maria-Ioanna Christodoulou, Georgios Germanidis, Stamatios Theocharis
    Cancers.2023; 15(10): 2795.     CrossRef
  • Loss of toll-like receptor 5 potentiates spontaneous hepatocarcinogenesis in farnesoid X receptor–deficient mice
    Rachel M. Golonka, Beng San Yeoh, Piu Saha, Amira Gohara, Ramakumar Tummala, Stanislaw Stepkowski, Amit K. Tiwari, Bina Joe, Frank J. Gonzalez, Andrew T. Gewirtz, Matam Vijay-Kumar
    Hepatology Communications.2023;[Epub]     CrossRef
  • The role of neutrophil extracellular traps and proinflammatory damage-associated molecular patterns in idiopathic inflammatory myopathies
    Wenlan Ma, Jiarui Zhu, Ling Bai, Peipei Zhao, Feifei Li, Sigong Zhang
    Clinical and Experimental Immunology.2023; 213(2): 202.     CrossRef
  • Fusobacterium nucleatum-triggered neutrophil extracellular traps facilitate colorectal carcinoma progression
    Xuehua Kong, Yu Zhang, Linwei Xiang, Yan You, Yaqian Duan, Yuqing Zhao, Shue Li, Rui Wu, Jiangbo Zhang, Lan Zhou, Liang Duan
    Journal of Experimental & Clinical Cancer Research.2023;[Epub]     CrossRef
  • Advancements in the Alcohol-Associated Liver Disease Model
    Lin Zhu, Hai-Di Li, Jie-Jie Xu, Juan-Juan Li, Miao Cheng, Xiao-Ming Meng, Cheng Huang, Jun Li
    Biomolecules.2022; 12(8): 1035.     CrossRef
  • Emerging Role of Neutrophil Extracellular Traps in Gastrointestinal Tumors: A Narrative Review
    Yujun Zhang, Jingjing Song, Yiwei Zhang, Ting Li, Jie Peng, Haonan Zhou, Zhen Zong
    International Journal of Molecular Sciences.2022; 24(1): 334.     CrossRef
  • 9,961 View
  • 231 Download
  • 50 Web of Science
  • Crossref
Special topic: Alcoholic liver diseases
The 14th International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis (ISALPDC)

Hepatic neoplasm

Alcohol and hepatocarcinogenesis
Makiko Taniai
Clin Mol Hepatol 2020;26(4):736-741.
Published online October 1, 2020
DOI: https://doi.org/10.3350/cmh.2020.0203
An excessive alcohol intake may result in fatty liver, acute/chronic hepatitis, cirrhosis, and lead to hepatocellular carcinoma (HCC). The aim of this review is to clarify the present condition and the mechanisms of alcohol-related hepatocarcinogenesis and clinical risk factors for alcohol-related HCC. There are several possible mechanisms through which alcohol may induce hepatocarcinogenesis, including the mutagenic effects of acetaldehyde toxicity through the formation of protein and DNA adducts and the production of reactive oxygen species due to the excessive hepatic deposition of iron, changes to lipid peroxidation and metabolism, inflammation and an impaired immune response and modifications to DNA methylation. Furthermore, it has been reported that alcohol accelerates liver carcinogenesis through several signaling pathways including gut-liver axis. From a clinical perspective, it is well known that alcohol interacts with other factors, such as age, gender, viral hepatitis, obesity, and diabetes leading to an increased risk of HCC.

Citations

Citations to this article as recorded by  Crossref logo
  • Leveraging cancer metabolism to translate into effective therapeutics
    Jie Xu, Linlin Guo, Yi Wang, Xiaoping Li, Ping Yi, Chunming Cheng
    Seminars in Cancer Biology.2026; 118: 44.     CrossRef
  • Liver cancer risk stratification using deep learning on nationwide longitudinal health screening data: a retrospective cohort study
    Yewon Choi, Sungmin Cho, Changdai Gu, Chungho Kim, Bomi Park, Hwiyoung Kim
    BMC Medical Informatics and Decision Making.2026;[Epub]     CrossRef
  • A Multi-Stimuli-Responsive Steroid-Based Nanosystem for Apigenin Delivery and Time-Dependent Anti-HCC Activity In Vitro
    Luwen Luo, Yaoxiao Liang, Luchang Chen, Weipeng Yang, Shenglin You, Chunying Luo, Cheng Lin
    Journal of Inorganic and Organometallic Polymers and Materials.2026;[Epub]     CrossRef
  • NADH-Activated Near-Infrared Fluorescent Probe for Efficient Screening of ADH/ALDH2 Dual Agonists for Alcohol Detoxification
    Jiwei Li, Xunfang Ding, Qilin Zhou, Lei Sun, Jin Yan, Qian Li, Hao Liu, Renshi Li, Fanchao Feng, Bo Chen, Jiangwei Tian
    Analytical Chemistry.2026; 98(5): 4296.     CrossRef
  • Age-specific patterns and trends of primary liver cancer: a worldwide incidence analysis
    Yi Li, Chengnan Guo, Haili Wang, Xin Zhang, Shuzhen Zhao, Jingkun Hu, Zhenqiu Liu, Tiejun Zhang
    International Journal of Surgery.2026; 112(2): 2536.     CrossRef
  • Liver cirrhosis: epidemiology, risk factors, potential complications, and possible treatment strategies
    Md. Omar Faruk, Md. Kausar Uddin Ahmed, Nabila Ishrat, Sabrina Alam Mrittika, Md. Sakibul Alam, Md. Mahmudul Hasan, Farjana Afrin Tanjum, Nor Mohammad, Md. Ashiq Mahmud, Mohammad Nurul Amin
    Gastroenterology & Endoscopy.2026; 4(2): 117.     CrossRef
  • Primary Liver Cancer Trends Worldwide and in China: Analysis of GLOBOCAN 2022 Data and Disease Management Implications
    Jiayan Yan, Jiayi Wang, Jian Fan, Xinyi Cui, Yuxi Zhang, Xinrong Yang, Qiang Gao, Zhenbin Ding, Zhaoyou Tang, Jia Fan, Dan G. Duda, Ao Huang, Jian Zhou
    Portal Hypertension & Cirrhosis.2026; 5(1): 65.     CrossRef
  • UHRF1 drives hepatocellular carcinoma progression via epigenetic repression of SFMBT2
    Zekai Hu, Qi Sun, Weiliang Xia, Zenglei He
    Scientific Reports.2026;[Epub]     CrossRef
  • Global, regional, and national burden of liver cancer due to alcohol use, 1990–2021: results from the Global Burden of Disease study 2021
    Qihong Wang, Wen Jia, Jiao Liu, Qian Zhao, Zhuo Yang
    European Journal of Gastroenterology & Hepatology.2025; 37(4): 466.     CrossRef
  • Construction and validation of a diagnostic model for cholangiocarcinoma based on tumor-educated platelet RNA expression profiles
    Haiyang Hu, Jiefeng He, Haoliang Zhao
    Oncologie.2025; 27(2): 277.     CrossRef
  • Role of hepatotropic viruses in promoting hepatocellular carcinoma—current knowledge and recent advances
    Piotr Starnawski, Klaudia Nowak, Zuzanna Augustyn, Dominik Malicki, Aleksandra Piąta, Dominika Lorek, Jakub Janczura
    Medical Oncology.2025;[Epub]     CrossRef
  • Current status and perspectives of molecular mechanisms of gender difference in hepatocellular carcinoma: The tip of the iceberg?
    Zhi-Quan Xu, Shi-Qiao Luo, Zhong-Jun Wu, Rui Liao
    BioScience Trends.2025; 19(3): 266.     CrossRef
  • The epidemiology, etiology, and future prophylactic options for cancers in Mainland China
    Hongsen Chen, Jie Xu, Wenbin Liu, Xi Chen, Ping Li, Guangwen Cao
    Frontiers in Oncology.2025;[Epub]     CrossRef
  • Reactive Oxygen Species as Key Molecules in the Pathogenesis of Alcoholic Fatty Liver Disease and Nonalcoholic Fatty Liver Disease: Future Perspectives
    Zhiqing Zhang, Hong Yang, Fei Han, Peng Guo
    Current Issues in Molecular Biology.2025; 47(6): 464.     CrossRef
  • Hepatocellular carcinoma in patients without cirrhosis
    Karina Sato-Espinoza, Mayra Valdivia-Herrera, Perapa Chotiprasidhi, Javier Diaz-Ferrer
    World Journal of Gastroenterology.2025;[Epub]     CrossRef
  • Gut bacteria and the host synergies promote resveratrol metabolism and induce tolerance in ALD mice
    Song-xia Zhang, Fang-fang Hu, Huan Chen, Jing Guo, Zhong-wen Xiang, Xin Ding, Meng-ling Ye, Wen-li Ye, Jun-hong Chen, Xin Wang, Wen-jing Han, Hong-hao Zhou, Wei Zhang, Yun Huang, Lie-lin Wu, Guang-hui Lian, Yao Chen
    npj Biofilms and Microbiomes.2025;[Epub]     CrossRef
  • Cis-Regulatory Alterations in FOXP4 Modulate Esophageal Cancer Susceptibility Induced by Chronic Alcohol Exposure
    Siyuan Niu, Jialing Ma, Shasha Liu, Yueping Li, Xinying Yue, Miaoxin Pan, Lina Song, Yutong Wu, Zifei Yang, Yuqian Tan, Linglong Gu, Chaolong Wang, Jiang Chang
    Cancer Research.2025; 85(14): 2591.     CrossRef
  • Identification of a novel ferroptosis-related gene signature in hepatocellular carcinoma: clinical significance, tumor microenvironment, drug sensitivity, and gene landscape analysis
    Yunzhao Hu, Chenchen Hao, Chengyuan Dong, Ping Tao, Jia Wang, Qun Lu
    Discover Oncology.2025;[Epub]     CrossRef
  • Precision Strategy for Hepatocellular Carcinoma Surveillance after Hepatitis C Cure: Debates across Guidelines
    Masaaki Mino, Eiji Kakazu, Tatsuya Kanto
    Gut and Liver.2025; 19(5): 651.     CrossRef
  • Construction of a hepatocellular carcinoma high-risk population rating scale and independent predictors' assessment
    Manyu Li, Jing Sun, Yan Wang, Jun Ma, Xiaotian Hao, Yan Liu, Cheng Zhou, Haiwei Zhou
    The American Journal of the Medical Sciences.2024; 367(3): 181.     CrossRef
  • Contributing roles of mitochondrial dysfunction and hepatocyte apoptosis in liver diseases through oxidative stress, post-translational modifications, inflammation, and intestinal barrier dysfunction
    Karli R. LeFort, Wiramon Rungratanawanich, Byoung-Joon Song
    Cellular and Molecular Life Sciences.2024;[Epub]     CrossRef
  • Inequities in primary liver cancer in Europe: The state of play
    Loreta A. Kondili, Jeffrey V. Lazarus, Peter Jepsen, Frank Murray, Jörn M. Schattenberg, Marko Korenjak, Lucia Craxì, Maria Buti
    Journal of Hepatology.2024; 80(4): 645.     CrossRef
  • Components from Curcuma longa (Turmeric) Against Hepatobiliary Diseases Based on Gut–Liver Axis: Pharmacotherapeutic Properties and Potential Clinical Applications
    Tianhui Gao, Shuyi Wang, Zongping Zhu, Liting Lin, Yirong Luo, Meigui Lu, Wan Liao
    The American Journal of Chinese Medicine.2024; 52(02): 387.     CrossRef
  • Impact of MAFLD criteria on postoperative recurrence of non-B, non-C HCC
    Yusuke Johira, Takashi Nakahara, Kenji Yamaoka, Yasutoshi Fujii, Shinsuke Uchikawa, Hatsue Fujino, Atsushi Ono, Eisuke Murakami, Tomokazu Kawaoka, Daiki Miki, Masataka Tsuge, Shiro Oka
    European Journal of Gastroenterology & Hepatology.2024; 36(4): 430.     CrossRef
  • A Review: Cytochrome P450 in Alcoholic and Non-Alcoholic Fatty Liver Disease
    Yu-Jie Jiang, Ye-Ming Cao, Yong-Bing Cao, Tian-Hua Yan, Cheng-Lin Jia, Ping He
    Diabetes, Metabolic Syndrome and Obesity.2024; Volume 17: 1511.     CrossRef
  • A polygenetic risk score combined with environmental factors better predict susceptibility to hepatocellular carcinoma in Chinese population
    Yuanlin Zou, Jicun Zhu, Caijuan Song, Tiandong Li, Keyan Wang, Jianxiang Shi, Hua Ye, Peng Wang
    Cancer Medicine.2024;[Epub]     CrossRef
  • CRISPR/Cas9 screen reveals that targeting TRIM34 enhances ferroptosis sensitivity and augments immunotherapy efficacy in hepatocellular carcinoma
    Feifan Yao, Suiqing Zhou, Ruizhi Zhang, Yining Chen, Wei Huang, Kai Yu, Nanmu Yang, Xiangjun Qian, Xiaofeng Tie, Jiali Xu, Yu Zhang, Tasiken Baheti, Jing Xu, Xinzheng Dai, Xiaopei Hao, Liren Zhang, Xuehao Wang, Qing Li
    Cancer Letters.2024; 593: 216935.     CrossRef
  • Risk of Hepatocellular Carcinoma by Steatotic Liver Disease and Its Newly Proposed Subclassification
    Byeong Geun Song, Aryoung Kim, Myung Ji Goh, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Dong Hyun Sinn
    Liver Cancer.2024; 13(5): 561.     CrossRef
  • Causal associations between platelet count, alcohol consumption, and the risk of liver hepatocellular carcinoma based on a Mendelian randomization study
    Lihua Yu, Leisheng Wang, Yuzheng Xue, Yilin Ren, Tianhao Liu, Hao Hu
    Frontiers in Endocrinology.2024;[Epub]     CrossRef
  • Hepatocellular Carcinoma: Prevention, Diagnosis, and Treatment
    Fei Feng, Yue Zhao
    Medical Principles and Practice.2024; 33(5): 414.     CrossRef
  • Inflammatory Response in the Pathogenesis and Treatment of Hepatocellular Carcinoma: A Double-Edged Weapon
    Linda Galasso, Lucia Cerrito, Valeria Maccauro, Fabrizio Termite, Irene Mignini, Giorgio Esposto, Raffaele Borriello, Maria Elena Ainora, Antonio Gasbarrini, Maria Assunta Zocco
    International Journal of Molecular Sciences.2024; 25(13): 7191.     CrossRef
  • Meaningful nomograms based on systemic immune inflammation index predicted survival in metastatic pancreatic cancer patients receiving chemotherapy
    Yanan Sun, Jiahe Hu, Rongfang Wang, Xinlian Du, Xiaoling Zhang, Jiaoting E, Shaoyue Zheng, Yuxin Zhou, Ruishu Mou, Xuedong Li, Hanbo Zhang, Ying Xu, Yuan Liao, Wenjie Jiang, Lijia Liu, Ruitao Wang, Jiuxin Zhu, Rui Xie
    Cancer Medicine.2024;[Epub]     CrossRef
  • Alcohol does not impact chronic hepatitis C treatment outcomes but increases risk for progressive liver disease: Findings from a prospective multicentre Australian study (OPERA‐C)
    Paul J. Clark, Patricia C. Valery, Simone I. Strasser, Martin Weltman, Alex Thompson, Miriam T. Levy, Barbara Leggett, Amany Zekry, Julian Rong, Marie Sinclair, Jacob George, William Sievert, Gerry MacQuillan, Edmund Tse, Amanda Nicoll, Amanda Wade, Wendy
    Drug and Alcohol Review.2024; 43(6): 1559.     CrossRef
  • Role of Epigenetic Factors in Determining the Biological Behavior and Prognosis of Hepatocellular Carcinoma
    Sami Akbulut, Zeynep Kucukakcali, Tevfik Tolga Sahin, Cemil Colak, Sezai Yilmaz
    Diagnostics.2024; 14(17): 1925.     CrossRef
  • Significance of Immune and Non-Immune Cell Stroma as a Microenvironment of Hepatocellular Carcinoma—From Inflammation to Hepatocellular Carcinoma Progression
    Jacek Baj, Magdalena Kołodziej, Joanna Kobak, Jacek Januszewski, Kinga Syty, Piero Portincasa, Alicja Forma
    International Journal of Molecular Sciences.2024; 25(19): 10233.     CrossRef
  • Epigenetic tuning of tumour-associated macrophages (TAMs): a potential approach in hepatocellular carcinoma (HCC) immunotherapy
    Israa M. Helal, Monica A. Kamal, Mostafa K. Abd El-Aziz, Hend M. El Tayebi
    Expert Reviews in Molecular Medicine.2024;[Epub]     CrossRef
  • Reply to correspondence on “Metformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapy”
    Seren M. Gedallovich, Paul Y. Kwo
    Clinical and Molecular Hepatology.2024; 30(4): 1050.     CrossRef
  • Comprehensive review and updated analysis of DNA methylation in hepatocellular carcinoma: From basic research to clinical application
    Lin Su, Jiawen Bu, Jiahui Yu, Mila Jin, Guanliang Meng, Xudong Zhu
    Clinical and Translational Medicine.2024;[Epub]     CrossRef
  • Application of nanotechnology in the treatment of hepatocellular carcinoma
    Liu Cai, Yanyuan Du, Hongtai Xiong, Honggang Zheng
    Frontiers in Pharmacology.2024;[Epub]     CrossRef
  • ADRB2 serves as a novel biomarker and attenuates alcoholic hepatitis via the SIRT1/PGC-1α/PPARα pathway: integration of WGCNA, machine learning and experimental validation
    Li Song, Shuo Huang, Honghao Yan, Qing Ma, Qihan Luo, Jiang Qiu, Minxia Chen, Zongyuan Li, He Jiang, Yufan Chen, Fangming Chen, Yu Du, Haozhe Fu, Lisha Zhao, Kanglu Zhao, Ping Qiu
    Frontiers in Pharmacology.2024;[Epub]     CrossRef
  • A nonlinear relationship between alcohol consumption and cognitive function in elderly people: a population-based study from NHANES 2011–2014
    Kaiqi Chen, Yunhua Li, Rui Yue, Zhao Jin, Shikui Cui, Xijian Zhang, Danping Zhu, Qihui Li
    Frontiers in Aging Neuroscience.2024;[Epub]     CrossRef
  • Identification and validation of functional roles for three MYC-associated genes in hepatocellular carcinoma
    Sha Li, Pei Xue, Xun Diao, Qi-Yu Fan, Kun Ye, Xiao-Mei Tang, Jia Liu, Zhong-Yan Huang, Qing-Hai Tang, Cheng-You Jia, Rui Xin, Zhong-Wei Lv, Ji-Bin Liu, Yu-Shui Ma, Da Fu
    Journal of Advanced Research.2023; 54: 133.     CrossRef
  • The Roles of Epigenetic Regulation and the Tumor Microenvironment in the Mechanism of Resistance to Systemic Therapy in Hepatocellular Carcinoma
    Kyoko Oura, Asahiro Morishita, Sae Hamaya, Koji Fujita, Tsutomu Masaki
    International Journal of Molecular Sciences.2023; 24(3): 2805.     CrossRef
  • Discontinuing Hepatitis Activity Reduced Hepatocellular Carcinoma Recurrence after Primary Curative Therapy
    Chern-Horng Lee, Chien-Heng Shen, Cho-Li Yen, Tzung-Hai Yen, Sen-Yung Hsieh
    Journal of Personalized Medicine.2023; 13(3): 397.     CrossRef
  • The effects of moderate alcohol consumption on non-alcoholic fatty liver disease
    Hyunwoo Oh, Won Sohn, Yong Kyun Cho
    Clinical and Molecular Hepatology.2023; 29(Suppl): S261.     CrossRef
  • Ring finger protein 12 activates AKT signalling to promote the progression of liver cancer by interacting with EGFR
    Chengpeng Yu, Dean Rao, Tiantian Wang, Jiaqi Sheng, Enjun Lv, Long Zhang, Xun Lu, Jingjing Yu, Huifang Liang, Jia Song, Wenjie Huang
    Journal of Cellular and Molecular Medicine.2023; 27(11): 1523.     CrossRef
  • The association between alcohol consumption and the risk of hepatocellular carcinoma according to glycemic status in Korea: A nationwide population-based study
    Eun Ju Cho, Goh Eun Chung, Jeong-Ju Yoo, Yuri Cho, Dong Wook Shin, Yoon Jun Kim, Jung-Hwan Yoon, Kyungdo Han, Su Jong Yu
    PLOS Medicine.2023; 20(6): e1004244.     CrossRef
  • Increased age, bilirubin, international normalized ratio, and creatinine score to triglyceride ratio are associated with alcohol-associated primary liver carcinoma: a single-centered retrospective study
    Xiaoqing Jia, Rong Li, Xiaoting Zhang, Tao Zhou, Dalong Sun, Na Yang, Zheng Luo
    Lipids in Health and Disease.2023;[Epub]     CrossRef
  • Association between pro-inflammatory diet and liver cancer risk: a systematic review and meta-analysis
    Kaixia Chen, Fen Yang, Xinhong Zhu, Guiyuan Qiao, Chunmei Zhang, Junxiu Tao, Xiaolian Gao, Mingzhong Xiao
    Public Health Nutrition.2023; 26(12): 2780.     CrossRef
  • Alcohol: Immunomodulatory Effects and Cancer
    Juan C. Molina, Jesús D. Guerrero-Morán, Claudia González-Espinosa
    Revista de Investigación Clínica.2023; 75(3): 129.     CrossRef
  • Epigenetics in hepatocellular carcinoma
    Ganji Purnachandra Nagaraju, Begum Dariya, Prameswari Kasa, Sujatha Peela, Bassel F. El-Rayes
    Seminars in Cancer Biology.2022; 86: 622.     CrossRef
  • Alcohol triggered bile acid disequilibrium by suppressing BSEP to sustain hepatocellular carcinoma progression
    Wenbo Chen, Qisong Zhang, Ming Ding, Jingjing Yao, Yajuan Guo, Wenxin Yan, Shaofang Yu, Qinghong Shen, Min Huang, Yaqiu Zheng, Yuefang Lin, Ying Wang, Zhongqiu Liu, Linlin Lu
    Chemico-Biological Interactions.2022; 356: 109847.     CrossRef
  • GARS is implicated in poor survival and immune infiltration of hepatocellular carcinoma
    Jinghui Wang, Bing Yang, Dingxue Wang, Rui Han, Zhanyang Bi, Lizhu Lin
    Cellular Signalling.2022; 94: 110302.     CrossRef
  • The pathogenesis of liver cancer and the therapeutic potential of bioactive substances
    Song Gao, Xingyue Jiang, Liang Wang, Shanshan Jiang, Hanyuan Luo, Yan Chen, Cheng Peng
    Frontiers in Pharmacology.2022;[Epub]     CrossRef
  • The Effect of Alcohol Consumption in Unresectable Hepatocellular Carcinoma with Transarterial Chemoembolization
    Bo Sun, Lijie Zhang, Dongqiao Xiang, Qing Li, Yanqiao Ren, Yanyan Cao, Tao Sun, Weihua Zhang, Linxia Wu, Licheng Zhu, Lei Chen, Huangxuan Zhao, Chuansheng Zheng, Alessandro Granito
    Journal of Oncology.2022; 2022: 1.     CrossRef
  • Association of Diabetes Mellitus and Alcohol Abuse with Cancer: Molecular Mechanisms and Clinical Significance
    Bao Q. Lam, Rashmi Srivastava, Jason Morvant, Sharmila Shankar, Rakesh K. Srivastava
    Cells.2021; 10(11): 3077.     CrossRef
  • The Emerging Influences of Alpha-Fetoprotein in the Tumorigenesis and Progression of Hepatocellular Carcinoma
    Ye Xu, Qinglong Guo, Libin Wei
    Cancers.2021; 13(20): 5096.     CrossRef
  • 12,318 View
  • 235 Download
  • 59 Web of Science
  • Crossref